| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 01/02/2013 | CN102846667A Preparation method for nanometer Periplaneta americana through low temperature drying |
| 01/02/2013 | CN102846638A Veterinary drug for treating necrotic enteritis of chicken |
| 01/02/2013 | CN102846637A Veterinary drug for treating dysbacteriosis of chicken |
| 01/02/2013 | CN102846620A Composition with alcohol dispelling and sobering effects and preparation method thereof |
| 01/02/2013 | CN102846613A Formulations for parenteral delivery of compounds and uses thereof |
| 01/02/2013 | CN102846607A Solid preparation comprising cevimeline hydrochloride as active component and application thereof |
| 01/02/2013 | CN102846598A Application of coumarin in preparing formation inhibitors of advanced glycation end products (AGEs) |
| 01/02/2013 | CN102846594A New application of isopentene-based flavonoids compound in drug |
| 01/02/2013 | CN102846587A Fatty acid composition, plant extract, pharmaceutical preparation, and application thereof |
| 01/02/2013 | CN102846573A Silibinin double-layer slow-release tablets and preparation method thereof |
| 01/02/2013 | CN102846571A Esomeprazole magnesium micro-tablet |
| 01/02/2013 | CN102846559A Pantoprazole sodium freeze-dry preparation and preparation method thereof |
| 01/02/2013 | CN102846551A Liver-targeting high-density lipoprotein analogue nano-particles, preparation method thereof, and application thereof |
| 01/02/2013 | CN102846545A Andrographolide emulsion and preparation method thereof |
| 01/02/2013 | CN102846529A Toothpaste and preparation method thereof |
| 01/02/2013 | CN102846528A Toothpaste |
| 01/02/2013 | CN102846507A Health-care medicinal toothpaste |
| 01/02/2013 | CN102845754A Ginger extract and preparation method thereof |
| 01/02/2013 | CN102845685A Equol-containing fermented soybean hypocotyl material |
| 01/02/2013 | CN102845607A Novel antibacterial antiviral feed additive |
| 01/02/2013 | CN102845568A Tea for moistening intestines |
| 01/02/2013 | CN102845422A Antimicrobial compositions and methods |
| 01/02/2013 | CN102357215B Ointment for treating right hypochondriac distention and pain caused by acute and chronic cholecystitis |
| 01/02/2013 | CN102333534B Pharmaceutical composition comprising a proton pump inhibitor and a prebiotic for the treatment of ulcerous lesions of the stomach and duodenum |
| 01/02/2013 | CN102319370B Chinese medicinal preparation for treating typhoid fever |
| 01/02/2013 | CN102319329B Mass appetizing tablets |
| 01/02/2013 | CN102225195B Porcine interferon-gamma composite medicament and application thereof |
| 01/02/2013 | CN102218110B Four-medicine grinding soup concentrated pill and preparation method thereof |
| 01/02/2013 | CN102134312B Amphipathic compound of curcumin derivates and polyoxyethylene as well as preparation method and application thereof |
| 01/02/2013 | CN102106829B Sodium rabeprazole freeze-dried powder injection for injection, preparation method thereof and detection method thereof |
| 01/02/2013 | CN102088981B Sialic acid to support salivation |
| 01/02/2013 | CN102085188B Novel lansoprazole enteric pellet and preparation method thereof |
| 01/02/2013 | CN102068426B New application of Ginkgolide B derivative in medicament preparation |
| 01/02/2013 | CN101948859B shRNA expression vector expressed by specificity inhibitor SET protein, construction method and application thereof |
| 01/02/2013 | CN101933977B Traditional Chinese medicine composition against tooth sensitivity, toothpaste and preparation method thereof |
| 01/02/2013 | CN101850061B Making method of red polygonatum ginseng |
| 01/02/2013 | CN101848708B Corticosteroids to treat epothilone or epothilone derivative induced diarrhea |
| 01/02/2013 | CN101830889B 嘧啶衍生物 Pyrimidine derivatives |
| 01/02/2013 | CN101687003B Novel pharmaceutical composition for use as a laxative |
| 01/02/2013 | CN101663399B An anti-hcv vaccine and preparation methods and uses thereof |
| 01/02/2013 | CN101646340B Production of a viable, storable worm egg suspension |
| 01/02/2013 | CN101600452B Pharmaceutical composition containing arazyme for the prevention of liver dysfunction |
| 01/02/2013 | CN101480381B Coenzyme Q10 pharmaceutical composition |
| 01/02/2013 | CN101444511B Low dose entecavir formulation and use |
| 01/01/2013 | US8344017 Anti-hepatitis C virus agents and anti-HIV agents |
| 01/01/2013 | US8343988 Inhibitors of histone deacetylase |
| 01/01/2013 | US8343976 Compounds, compositions and methods comprising pyrazole derivatives |
| 01/01/2013 | US8343937 Methods and compositions for treating flaviviruses and pestiviruses |
| 01/01/2013 | US8343763 Heterocyclic derivatives as modulators of ion channels |
| 01/01/2013 | US8343556 Composition for treating and/or preventing periodontal disease |
| 01/01/2013 | US8343483 Selection and use of lactic acid bacteria for reducing dental caries and bacteria causing dental caries |
| 12/27/2012 | WO2012177707A1 Phosphate esters of gyrase and topoisomerase inhibitors |
| 12/27/2012 | WO2012177565A2 Regulation of macrophage activation using mir - 125b |
| 12/27/2012 | WO2012176140A1 Process for the preparation of dexlansoprazole |
| 12/27/2012 | WO2012176061A1 Trpv1 antagonists including dihydroxy substituent and uses thereof |
| 12/27/2012 | WO2012175698A1 Therapeutic use of all-trans retinoic acid (atra) in patients suffering from alcoholic liver disease |
| 12/27/2012 | WO2012175676A2 Molecules specifically binding pancreatic beta cells biomarkers |
| 12/27/2012 | WO2012175434A1 Pharmaceutical formulations comprising vestipitant |
| 12/27/2012 | WO2012175049A1 Amide compound, preparation method and uses thereof |
| 12/27/2012 | WO2012174926A1 N-substituted isopropyldimethyl azulene sulfonamide derivatives, and preparation method and use thereof |
| 12/27/2012 | WO2012174730A1 Preparative method and use of zyj-d08a and its epimers as histone deacetylase inhibitors |
| 12/27/2012 | WO2012135426A3 Anti-bacterial and mineralizing calcium phosphate compositions |
| 12/27/2012 | US20120330019 Hepatitis C Virus Inhibitors |
| 12/27/2012 | US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 12/27/2012 | US20120329863 Isolation of a dual cox-2 and 5-lipoxygenase inhibitor from acacia |
| 12/27/2012 | US20120329855 Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf |
| 12/27/2012 | US20120329848 Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| 12/27/2012 | US20120329846 Therapeutic agent for inflammatory bowel disease and tnf-alpha production inhibitor |
| 12/27/2012 | US20120329834 Compounds for the treatment of mitochondrial diseases |
| 12/27/2012 | US20120329833 Use of antagonists of the cbi receptor for the manufacture of a composition useful for the treatment of hepatic diseases |
| 12/27/2012 | US20120329804 Pyridopyrazindione Derivative and its Use as an Antiulcer Drug |
| 12/27/2012 | US20120329802 Metalloenzyme inhibitor compounds |
| 12/27/2012 | US20120329782 Azepine inhibitors of janus kinases |
| 12/27/2012 | US20120329778 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 12/27/2012 | US20120329776 Heterocyclic compounds and uses thereof |
| 12/27/2012 | US20120329773 Bicyclic ring system substituted amide functionalised phenols as medicaments |
| 12/27/2012 | US20120329764 Methods and compositions for the treatment of migraine headaches |
| 12/27/2012 | US20120329762 Anti-thrombotic compounds |
| 12/27/2012 | US20120329758 Combined Treatment Utilizing VB-201 |
| 12/27/2012 | US20120329757 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 12/27/2012 | US20120329742 Use of antifungal compositions to treat upper gastrointestinal conditions |
| 12/27/2012 | US20120329736 Treatment for gastrointestinal disorders using a selective, site-activated binding system |
| 12/27/2012 | US20120329717 Novel omega conotoxin peptides |
| 12/27/2012 | US20120329710 Methods of Inducing Regulated Pancreatic Hormone Production in Non-Pancreatic Islet Tissues |
| 12/27/2012 | US20120329708 Glucagon/glp-1 receptor co-agonists |
| 12/27/2012 | US20120329707 Glucagon/glp-1 receptor co-agonists |
| 12/27/2012 | US20120329706 Hepatitis b virus pre-s1 derived synthetic polypeptides and uses thereof |
| 12/27/2012 | US20120328718 Pharmaceutical compositions |
| 12/27/2012 | US20120328712 Carbon monoxide releasing rhenium compounds for medical use |
| 12/27/2012 | US20120328711 Antimicrobial system for selective, site-activated binding at target sites |
| 12/27/2012 | US20120328710 Selective, site-activated binding of toxins at target sites |
| 12/27/2012 | US20120328706 Polymer particle delivery compositions and methods of use |
| 12/27/2012 | US20120328702 Nanoparticle compositions |
| 12/27/2012 | US20120328701 Nanoparticle compositions, formulations thereof, and uses therefor |
| 12/27/2012 | US20120328698 Coating method |
| 12/27/2012 | US20120328675 Film preparation containing medicament with unpleasant taste |
| 12/27/2012 | US20120328672 Composition and method of separating bentonite into particles having discrete size and density ranges capable of binding biological toxins and chemotherapeutic agents. |
| 12/27/2012 | US20120328661 Coumarin compounds as receptor modulators with therapeutic utility |
| 12/27/2012 | US20120328635 Chaperonin 10 variants |
| 12/27/2012 | US20120328632 Inhibition of leukocyte adhesion |